Aisling Capital

Aisling Capital is a venture capital and private equity firm investing in healthcare and biotechnology companies that is headquartered in New York City, New York and was founded in 2000.

The firms invests primarily in companies commercializing healthcare products, services, and technologies. Aisling Capital has raised about $1.8 billion in committed capital across 4 investment funds and has made 106 investments. Notable investments made by the firm include: Dermira, BridgeBio, Atreca, TransEnterix, ViewRay, T2 Biosystems, Arcus Biosciences, Aimmune Therapeutics, Eidos Therapeutics, and Avrobio.